Render Target: SSR
Render Timestamp: 2024-12-10T22:06:36.364Z
Commit: 611277b6de3cd1bb065350b6ef8d63df412b7185
XML generation date: 2024-09-30 01:59:59.034
Product last modified at: 2024-09-30T08:01:48.208Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

SNX5 (E4Q2X) Rabbit mAb #39138

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H M R
    SENSITIVITY Endogenous
    MW (kDa) 47
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 
    • M-Mouse 
    • R-Rat 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:50

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    SNX5 (E4Q2X) Rabbit mAb recognizes endogenous levels of total SNX5 protein.

    Species Reactivity:

    Human, Mouse, Rat

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu216 of human SNX5 protein.

    Background

    Sorting nexins (SNXs) are a family of cytoplasmic proteins characterized by the presence of a phosphatidylinositol 3-phosphate (PI3P) binding phox (PX) domain. This binding occurs mainly in the early endosome and allows for trafficking of the bound protein to either a degradative or recycling pathway (1). The sorting nexin family member SNX5 was identified in binding studies with Fanconi anemia complementation group A (FANCA) protein (2). In addition to the PX domain, STX5 has a Bin/Amphiphysin/Rvs (BAR) domain that can sense membrane curvature and induce membrane tubulation (3). Aberrant expression of SNX5 can contribute to tumorigenesis, invasion, and metastasis of several human cancers (4-7). Elevated expression of SNX5 has been reported in Parkinson’s disease, where it may have a role in promoting ferroptosis (8). Studies have found that SNX5 has an essential role in macropinocytosis (9). In addition, SNX5 is part of a complex involved in recognizing membrane curvature on autolysosomes and regulating recycling of autophagosomal components (10). In a genome-wide siRNA, SNX5 was found to be an essential protein involved in virus-mediated autophagy and immunity (11).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.